Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 14, 2020

SELL
$0.83 - $1.3 $1.93 Million - $3.02 Million
-2,323,000 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$0.97 - $1.94 $957,390 - $1.91 Million
-987,000 Reduced 29.82%
2,323,000 $2.3 Million
Q2 2019

Aug 14, 2019

BUY
$1.81 - $2.45 $147,426 - $199,554
81,451 Added 2.52%
3,310,000 $6.75 Million
Q1 2019

May 15, 2019

SELL
$2.3 - $3.27 $1.27 Million - $1.8 Million
-550,451 Reduced 14.57%
3,228,549 $7.91 Million
Q4 2018

Feb 14, 2019

BUY
$2.49 - $4.54 $2.65 Million - $4.83 Million
1,064,000 Added 39.19%
3,779,000 $9.79 Million
Q3 2018

Nov 14, 2018

SELL
$3.4 - $4.84 $1.48 Million - $2.11 Million
-435,000 Reduced 13.81%
2,715,000 $13 Million
Q2 2018

Aug 14, 2018

BUY
$3.03 - $4.98 $9.54 Million - $15.7 Million
3,150,000 New
3,150,000 $12.9 Million

Others Institutions Holding SENS

About Senseonics Holdings, Inc.


  • Ticker SENS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 465,447,008
  • Market Cap $144M
  • Description
  • Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...
More about SENS
Track This Portfolio

Track Polar Asset Management Partners Inc. Portfolio

Follow Polar Asset Management Partners Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Polar Asset Management Partners Inc., based on Form 13F filings with the SEC.

News

Stay updated on Polar Asset Management Partners Inc. with notifications on news.